Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket

European Journal of Pharmacology

Volumn 469, Issue 1-3, 2003, Pages 13-19

  Spisani, Susanna ^a   Turchetti, Marianna ^a   Varani, Katia ^a   Falzarano, Sofia ^a   Cavicchioni, Giorgio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chemotaxis; Human; Lysozyme release; N formylmethionyl peptide; Neutrophil; Receptor binding; Superoxide anion generation

Indexed keywords

AMINO ACID DERIVATIVE; AMINO ACID RECEPTOR; CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLASPARTIC ACID METHYL ESTER; FORMYLMETHIONYLLEUCYLGLUTAMINE METHYL ESTER; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLMETHIONYLLEUCYLSERINE METHYL ESTER; FORMYLMETHIONYLLEUCYLTYROSINE METHYL ESTER; LYSOZYME; PHENYLALANINE; SUPEROXIDE; TRIPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL FUNCTION; CHEMOTAXIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHILICITY; HYPOTHESIS; IN VITRO STUDY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0038054069     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01672-8     Document Type: Article

References (47)

1. Babior B.M., Hoyal C.R., Lehrer R.I., Ganz T. Antimicrobial activity of leukocytes. Ley K. Physiology of Inflammation. 2001;189-203 Oxford Univ. Press, Oxford.
2. Baggiolini M., Boulay F., Badwey J.A., Cornutte J.T. Activation of neutrophil leucocytes: chemoattractant receptors and respiratory burst. FASEB. 7:1993;1004-1010.
3. Boulay F., Tardiff M., Brouchon L., Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168:1990;1103-1109.
4. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 185:1982;264-275.
5. Cavicchioni G., Spisani S. A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. J. Pept. Res. 58:2001;257-262.
6. Cavicchioni G., Monesi L.G., Ferretti M.E., Fabbri E., Rizzuto O., Spisani S. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties. Arch. Pharm. 331:1998;368-370.
7. Dalpiaz A., Ferretti M.E., Vertuani G., Traniello S., Scatturin A., Spisani S. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor. Eur. J. Pharmacol. 436:2002;187-196.
8. Dalpiaz A., Spisani S., Biondi C., Fabbri E., Nalli M., Ferretti M.E. Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists. Current Drug Targets-Immune, Endocrine and Metabolic Disorders. 3:2003;33-42.
9. Dentino A.R., Antony Raj P., Bhandary K.K., Wilson M.E., Levine M.J. Role of peptide backbone conformation on biological activity of chemotactic peptides. J. Biol. Chem. 266:1991;18460-18468.
10. Dugas H., Laroche M., Ptak M., Labbé H. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH. Int. J. Pept. Protein Res. 41:1993;595-605.
11. Durstin M., Gao J.L., Tiffany H.L., Mc Dermott D., Murphy P.M. Differential expression of the members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201:1994;174-179.
12. 2+. Biochim. Biophys. Acta. 1359:1997;233-240.
13. Ferretti M.E., Spisani S., Pareschi M.C., Buzzi M., Cavallaro R., Traniello S., Reali E., Torrino I., Paglialunga Paradisi M., Pagani Zecchini G., Biondi C. Two new formylated peptides able to activate chemotaxis and respiratory burst selectively as tools for studying human neutrophil responses. Cell. Signal. 6:1994;91-101.
14. Ferretti M.E., Nalli M., Biondi C., Colamussi M.L., Pavan B., Traniello S., Spisani S. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogs. Cell. Signal. 13:2001;233-240.
15. Formaggio F., Pantano M., Crisma M., Toniolo C., Boesten W.H.J., Schoemaker H.E., Kamphuis J., Becker E.L. Backbone modified formyl-methionyl tripeptide chemoattractants. Bioorg. Med. Chem. Lett. 3:1993;953-956.
16. Freer R.J., Day A.R., Radding J.A., Schiffmann E., Aswanikumar S., Showell H.J., Becker E.L. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry. 19:1980;2404-2410.
17. Freer R.J., Day A.R., Muthukumaraswamy N., Pinon D., Wu A., Showell H.J., Becker E.L. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. Biochemistry. 21:1982;257-263.
18. Gao J.L., Chen H., Filie J.D., Kozac C.A., Murphy P.M. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics. 51:1998;270-276.
19. Harvath L., Aksamit R.R. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production. J. Immunol. 133:1984;1471-1476.
20. Ho P.P., Joung A.L., Southard G.L. Methyl ester of N-formylmethionyl-leucyl-phenylalanine: chemotactic responses of human blood monocytes and inhibition of gold compounds. Arthritis Rheum. 21:1978;133-136.
21. Iizawa O., Akamatsu H., Niwa Y. Neutrophil chemotaxis, phagocytosis, and generation of reactive oxygen species show a hierarchy of responsiveness to increasing concentrations of N-formyl-Met-Leu-Phe. Biol. Signals. 4:1995;14-18.
22. Koo C., Lefkowitz R.J., Snyderman R. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem. Biophys. Res. Commun. 106:1982;442-449.
23. Lajoie G., Kraus J.L. Rapid and efficient method for the N-formylation of C-blocked peptides. Peptides. 5:1984;653-654.
24. Le Y., Murphy P.M., Wang J.M. Formyl-peptide receptors revised. Trends Immunol. 11:2002;541-548.
25. Li Z., Jiag H., Xie W., Zhang Z., Smrcka A.W., Wu D. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science. 287:2000;1046-1049.
26. Marasco W.A., Phan S.H., Krutzsch H., Showell H.J., Feltner D.E., Nairn R., Becker E.L., Ward P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:1984;5430-5439.
27. Murphy P.M. The molecular biology of leucocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593-633.
28. Murphy P.M. The N-formyl-peptide-receptors. Horuk R. Chemoattractant Ligands and their Receptors. 1996;289-299 CRC Press, Boca Raton.
29. Prossnitz E.R., Ye R.D. The formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:1997;73-102.
30. Rot A., Henderson L.E., Copeland T.D., Leonard E.J. A series of six ligands for the human formyl: tetrapeptides with high chemotactic potency and efficacy. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7967-7971.
31. Schiffmann E., Corcoran B.A., Wahl S.M. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc. Natl. Acad. Sci. U. S. A. 72:1975;1059-1062.
32. Selvatici R., Falzarano S., Traniello S., Pagani Zecchini G., Spisani S. Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. Cell. Signal. 15:2003;377-383.
33. Spisani S., Breveglieri A., Fabbri E., Vertuani G., Rizzuto O., Cavicchioni G. Modification of the amide bond at position 3 in fMLP analogs select neutrophil functions. Pept. Res. 9:1996;279-282.
34. Spisani S., Ferretti M.E., Fabbri E., Alvoni S., Cavicchioni G. N-formyl-tripeptides substituted at the methionine residue by an aspartic or glutamic acid: effects on neutrophil biological activity. Prot. Peptide Letters. 5:1998;155-158.
35. Spisani S., Traniello S., Cavicchioni G., Formaggio F., Crisma M., Toniolo C. Probing structural requirements of fMLP receptor: on the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide. J. Pept. Sci. 7:2002;56-65.
36. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G protien-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189(2):1999;395-402.
37. Sukumar M., Antony Raj P., Balaram P., Becker E.L. A highly active chemotactic peptide analog incorporating the unusual residue 1-aminocyclohexanecarboxylic acid at position 2. Biochem. Biophys. Res. Commun. 128:1985;339-344.
38. Toniolo C., Bonora G.M., Showell H., Freer R.J. Structural requirements for formyl homooligopeptide chemoattractants. Biochemistry. 23:1984;698-704.
39. Toniolo C., Bonora G.M., Freer R.J., Kennedy S.P., Pittenger K.L., Becker E.L. Synthetic formyl-methionyl chemoattractants: a conformation-activity study of oxidized tripeptides. Peptides. 9:1988;1195-1205.
40. Toniolo C., Crisma M., Valle G., Bonora G.M., Polinelli S., Becker E.L., Freer R.J., Sudhanand R., Balaji Rao P., Balaram P., Sukumar M. Conformationally restricted For-Met-tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a Cα,α-dialkylated Gly at position 2. Pept. Res. 2:1989;275-281.
41. Torrini I., Pagani Zecchini G., Paglialunga Paradisi M., Lucente G., Gavuzzo E., Mazza F., Pochetti G., Spisani S., Giuliani A.L. Synthesis and properties of chemotactic peptide analogs: II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues. Int. J. Pept. Protein Res. 38:1991;495-504.
42. Torrini I., Pagani Zecchini G., Paglialunga Paradisi M., Lucente G., Gavuzzo E., Mazza F., Pochetti G., Traniello S., Spisani S. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe. Biopolymers. 34:1994;1-9.
43. Ye R.D., Boulay F. Structure and function of leukocyte chemoattractant receptor. Adv. Pharmacol. 39:1997;221-289.
44. Van Eeden S.F., Klut M.E., Walker B.A.M., Hogg J.C. The use of flow cytometry to measure neutrophil function. J. Immunol. Methods. 232:1999;23-43.
45. Vertuani G., Spisani S., Boggian M., Traniello S., Scatturin A. Conformational studies of synthetic tripeptide chemoattractants. J. Pept. Protein Res. 29:1987;525-532.
46. Wenzel-Seifert K., Seifert R. Chemoattractant-receptor-G-protein coupling. Ley K. Physiology of Inflammation. 2001;146-188 Oxford Univ. Press, Oxford.
47. Zigmond S., Hirsh J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:1973;387-391.